- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03015103
Safety Dermatological Assessment of Topical Use Product Through Dressings Predictive Studies for Evaluation of Photoirritation and Dermal Photosensitivity (SAF DER ASSESS)
January 5, 2017 updated by: Kley Hertz S/A
The purpose of this study is to prove the product tested does not cause photoirritation or photosensitization reactions when exposed to sun light.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
28
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age between 18 to 70 years old;
- Skin types: I (light caucasian) or III (light brown);
- Intact skin where the product will be applied;
- Agreement to comply with the test procedures and attend the clinic in the days and fixed times for medical assessments and application and reading of dressings
- Signature of informed consent form
Exclusion Criteria:
- Pregnancy and lactation
- Use of anti-inflammatory and immunosuppressive from 30 days up to three months prior to selection;
- Diseases that cause immune suppression;
- Use of photosensitizing drugs;
- History or photodermatoses activities;
- Personal or family history of photoinduced skin cancer;
- Presence of precursor lesions of skin cancer, such as melanocytic nevi and actinic keratoses;
- Intense sun exposure in the experiment area Use of new drugs and/or cosmetics during the experiment;
- Previous participation in a study with the same product under test;
- Relevant medical history or current evidence of alcohol or other drugs abuse;
- Known historical or suspected intolerance to any ingredient of the product under study (product under test or comparator);
- Sponsor's employees involved in the study, or close family member of an employee involved in the study;
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Experimental group
This study is designed as a single group assignment, because the 4 dressings (3 placebos and 1 containing the product) will be applied in all volunteers.
This means that the region in which the tested product will be applied will be compared with the other placebo regions in the same volunteer.
|
All the volunteers will receive the application of four dressings (3 placebos and 1 containing the tested product).
After a certain period of time, photoirritation and photosensitization will be measured through the evaluation of tested region.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Photoirritation as measured through the use of dressings containing tested product and placebo
Time Frame: 5 days
|
The photoirritation will be measured with the use of four dressings that will be applied in the volunteer (3 dresssings containing different placebos and 1 containing the product).
After some hours, the region is evaluated and radiated with UVA.
That procedure occurs during the period of five days.
|
5 days
|
|
Photosensitization as measured through the use of dressings containing tested product and placebo
Time Frame: 32 days
|
The photosensitization will be measured with the use of four dressings that will be applied in the volunteer (3 dresssings containing different placebos and 1 containing the product).
After some hours, the region is evaluated and radiated with UVA.
That procedure occurs during the period of 32 days.
|
32 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2017
Primary Completion (ANTICIPATED)
February 1, 2017
Study Registration Dates
First Submitted
December 29, 2016
First Submitted That Met QC Criteria
January 5, 2017
First Posted (ESTIMATE)
January 9, 2017
Study Record Updates
Last Update Posted (ESTIMATE)
January 9, 2017
Last Update Submitted That Met QC Criteria
January 5, 2017
Last Verified
December 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- Kley Hertz 006
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Skin Irritability
-
Kley Hertz S/ACompleted
-
Kley Hertz S/ACompleted
-
Kley Hertz S/AUnknown
-
National Institute of Mental Health (NIMH)Recruiting
-
National Institute of Mental Health (NIMH)RecruitingIrritabilityUnited States
-
Hospital de Clinicas de Porto AlegreCompleted
-
University of North Carolina, Chapel HillFoundation of Hope for the Research and Treatment of Mental IllnessNot yet recruitingIrritability | Depression - Major Depressive DisorderUnited States
-
University of OxfordWellcome Trust; Oxford Health Biomedical Research Centre (OH BRC) support schemeRecruitingDepression | Irritability | Depression - Major Depressive DisorderUnited Kingdom
-
Karuna Therapeutics, Inc., a Bristol Myers Squibb...Karuna Therapeutics, Inc., a Bristol Myers Squibb companyRecruitingSchizophrenia | Autism-Related IrritabilityUnited States, Japan, Argentina, Romania, Canada, France, Germany, Hungary, Poland, Spain
-
Geha Mental Health CenterChief Scientist, The Israel Ministry of ScienceCompletedAnger | Suicidal Ideation | Irritability | Suicidal Behavior | Externalizing BehaviorIsrael
Clinical Trials on Intimate Lubrificant Gel
-
Kley Hertz S/ACompleted
-
Kley Hertz S/ACompleted
-
Herbarium Laboratorio Botanico LtdaCompletedVaginal Diseases | Atrophic VaginitisBrazil
-
Johnson & Johnson Consumer and Personal Products...Completed
-
Kley Hertz S/ACompleted
-
Instituto PalaciosCompleted
-
McMaster UniversityEcho: Improving Women's Health in Ontario (formerly Ontario Women's Health...CompletedIntimate Partner Violence Against WomenCanada
-
The Hong Kong Polytechnic UniversityCompleted
-
ThuasneActive, not recruitingBreast Cancer SurgeryFrance